LS Investment Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,050
| Closed | -$376K | – | 324 |
|
|
2021
Q1 | $376K | Sell |
4,050
-740
| -15% | -$68.7K | 0.02% | 472 |
|
|
2020
Q4 | $429K | Buy |
4,790
+2,201
| +85% | +$197K | 0.02% | 477 |
|
|
2020
Q3 | $268K | Buy |
2,589
+1,100
| +74% | +$114K | 0.02% | 606 |
|
|
2020
Q2 | $118K | Buy |
1,489
+11
| +0.7% | +$872 | 0.01% | 934 |
|
|
2020
Q1 | $86K | Hold |
1,478
| – | – | 0.01% | 949 |
|
|
2019
Q4 | $80K | Hold |
1,478
| – | – | ﹤0.01% | 1186 |
|
|
2019
Q3 | $77K | Hold |
1,478
| – | – | ﹤0.01% | 1159 |
|
|
2019
Q2 | $71K | Hold |
1,478
| – | – | ﹤0.01% | 1195 |
|
|
2019
Q1 | $75K | Hold |
1,478
| – | – | ﹤0.01% | 1169 |
|
|
2018
Q4 | $88K | Sell |
1,478
-2,103
| -59% | -$125K | 0.01% | 1100 |
|
|
2018
Q3 | $236K | Sell |
3,581
-354
| -9% | -$23.3K | 0.01% | 772 |
|
|
2018
Q2 | $199K | Buy |
3,935
+87
| +2% | +$4.4K | 0.01% | 870 |
|
|
2018
Q1 | $203K | Sell |
3,848
-100
| -3% | -$5.28K | 0.01% | 837 |
|
|
2017
Q4 | $183K | Buy |
3,948
+2,553
| +183% | +$118K | 0.01% | 947 |
|
|
2017
Q3 | $56K | Buy |
1,395
+105
| +8% | +$4.22K | ﹤0.01% | 1312 |
|
|
2017
Q2 | $44K | Hold |
1,290
| – | – | ﹤0.01% | 1384 |
|
|
2017
Q1 | $37K | Sell |
1,290
-129
| -9% | -$3.7K | ﹤0.01% | 1413 |
|
|
2016
Q4 | $47K | Hold |
1,419
| – | – | ﹤0.01% | 1286 |
|
|
2016
Q3 | $45K | Buy |
1,419
+104
| +8% | +$3.3K | ﹤0.01% | 1257 |
|
|
2016
Q2 | $37K | Buy |
1,315
+117
| +10% | +$3.29K | ﹤0.01% | 1311 |
|
|
2016
Q1 | $44K | Buy |
1,198
+60
| +5% | +$2.2K | ﹤0.01% | 1215 |
|
|
2015
Q4 | $46K | Hold |
1,138
| – | – | ﹤0.01% | 1186 |
|
|
2015
Q3 | $32K | Buy |
1,138
+144
| +14% | +$4.05K | ﹤0.01% | 1317 |
|
|
2015
Q2 | $33K | Buy |
+994
| New | +$33K | ﹤0.01% | 1352 |
|